Infection that could reduce lifelong drugs for transplant patients shows promising resultsResearchers have spent a groundbreaking procedure that could avoid the need for transplant patients, to the rest of their lives to get a cocktail of drugs that from rejecting from rejecting develops stop their new organ, according to a series of papers in the August issue of Transplant International.
The team led by Professor Fred Fandrich from the University of Schleswig-Holstein in Kiel, Germany, a technique developed to tailor regulatory cells. The aim is to to fight infection, white blood cells from the blood of the transplant recipient and a highly complex process with cells from a living or deceased donor removed. The tailor-made cells are administered administered back to the patient. Continue reading “According to a series of papers in the August issue of Transplant International.”